Skew-normal factor analysis models with incomplete data von Liu, M., Lin, T.I.

Volltext

Constant elasticity of variance (CEV) option pricing model: Integration and detailed derivation von Hsu, Y.L., Lin, T.I., Lee, C.F.

Volltext

Fluorescence of fullerene derivatives at room temperature von Lin, S.K., Shiu, L.L., Chien, K.M., Luh, T.Y., Lin, T.I.

Volltext

Analysis of the iron-sulfur clusters within the complex I (NADH:ubiquinone oxidoreductase) isolated from potato tuber mitochondria von Lin, T.I, Sled, V.D, Ohnishi, T, Brennicke, A, Grohmann, L

Volltext

A review and outlook for integrated BIM application in green building assessment von Ansah, Mark Kyeredey, Chen, Xi, Yang, Hongxing, Lu, Lin, Lam, Patrick T.I.

Volltext

An integrated life cycle assessment of different façade systems for a typical residential building in Ghana von Ansah, Mark Kyeredey, Chen, Xi, Yang, Hongxing, Lu, Lin, Lam, Patrick T.I.

Volltext

Developing an automated BIM-based life cycle assessment approach for modularly designed high-rise buildings von Ansah, Mark Kyeredey, Chen, Xi, Yang, Hongxing, Lu, Lin, Lam, Patrick T.I.

Volltext

Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma after External Beam Radiotherapy von Lin, M., Shaaban, S., Chen, J.J., Bagatell, R., Lerman, B.J., Dubois, S.G., Shusterman, S., Ioakeim-Ioannidou, M., Yock, T.I., Elhalawani, H., Dusenbery, K.E., Vo, K.T., Diller, L.R., Marcus, K.J., MacDonald, S.M., Terezakis, S.A., Braunstein, S.E., Hill-Kayser, C.E., Haas-Kogan, D.A., Liu, K.X.

Volltext

69 Treatment Variation of Stable Ventricular Tachycardia in the Emergency Department von Arangan, J., Lin, J.S., Bouvet, S.C., Fazleabas, Q., Warton, E.M., Reed, M.E., Liu, T.I., Vinson, D.R., McLachlan, I.

Volltext

Measurements of electron transport in liquid and gas Xenon using a laser-driven photocathode von Tsang, T., Tarka, M., Fairbank, W., Rao, T., Wager, T., Kharusi, S. Al, Anton, G., Arnquist, I.J., Badhrees, I., Belov, V., Bhatta, T., Brown, E., Brunner, T., Cao, G.F., Cao, L., Cen, W.R., Chambers, C., Chana, B., Charlebois, S.A., Cleveland, B., Coon, M., Craycraft, A., Daniels, T., Darroch, L., De St. Croix, A., Der Mesrobian-Kabakian, A., DeVoe, R., Di Vacri, M.L., Ding, Y.Y., Dolinski, M.J., Dragone, A., Echevers, J., Elbeltagi, M., Fabris, L., Farine, J., Ferrara, S., Feyzbakhsh, S., Fontaine, R., Fucarino, A., Gallina, G., Gautam, P., Goeldi, D., Gratta, G., Hansen, E.V., Heffner, M., Hughes, M., Jamil, A., Jewell, M.J., Karelin, A., Kaufman, L.J., Koffas, T., Krücken, R., Kuchenkov, A., Lan, Y., Larson, A., Leonard, D.S., Li, Z., Licciardi, C., Lv, P., MacLellan, R., McElroy, T., Michel, T., Mong, B., Murray, K., Nusair, O., Odgers, K., Oriunno, M., Ortega, G.S., Overman, C.T., Pocar, A., Rescia, S., Retière, F., Robinson, A., Rossignol, T., Rowson, P.C., Roy, N., Runge, J., Skarpaas, K., Soma, A.K., St-Hilaire, G., Stiegler, T., Sun, X.L., Todd, J., Tolba, T., Vachon, F., Veeraraghavan, V., Vivo-Vilches, C., Vuilleumier, J.-L., Walent, M., Ward, M., Wei, W., Wen, L.J., Wichoski, U., Wu, S.X., Wu, W.H., Xia, Q., Yang, H., Yang, L., Zhou, Y., Ziegler, T.

Volltext

Effects of miR-30a-3p on autophagy and invasion in bladder cancer cell von Chou, K-Y., Chen, P-C., Ciou, P-C., Tsai, T-F., Chen, H-E., Lin, Y-C., Lin, J-F., Hwang, T.I.

Volltext

High SVR Rates with the Combination of ABT-493 + ABT-530 for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 1 or 2 Infection von Poordad, F, Felizarta, F, Wang, S, Asatryan, A, Hassanein, T, Aguilar, H, Lalezari, J, Overcash, J.S, Ng, T.I, Lovell, S.S, Lin, C.-W, Kort, J, Mensa, F.J

Volltext

100% SVR4 with ABT-493 and ABT-530 with or without Ribavirin in Treatment-Naïve HCV Genotype 3-Infected Patients with Cirrhosis von Kwo, P.Y, Wyles, D.L, Wang, S, Poordad, F, Gane, E, Maliakkal, B, Shiffman, M.L, Ng, T.I, Lin, C.-W, Liu, R, Kort, J, Mensa, F.J

Volltext

High Svr Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 Infection von Muir, A.J, Strasser, S, Wang, S, Shafran, S, Bonacini, M, Kwo, P, Wyles, D, Gane, E, Lovell, S.S, Lin, C.-W, Ng, T.I, Kort, J, Mensa, F.J

Volltext

High Efficacy of Abt-493 and Abt-530 in Hcv Genotype 1 Infected Patients who Have Failed Direct-Acting Antiviral-Containing Regimens: The Magellan-I Study von Poordad, F, Gordon, S.C, Asatryan, A, Felizarta, F, Reindollar, R.W, Landis, C, Fried, M.W, Bernstein, D.E, Ng, T.I, Lin, C.-W, Liu, R, Kort, J, Mensa, F.J

Volltext

High Efficacy and Favorable Safety of ABT-493 and ABT-530 Co-Administration for 12 Weeks in HCV Genotype 1-Infected Patients with Cirrhosis (Surveyor-I) von Gane, E, Poordad, F, Asatryan, A, Lalezari, J, Hassanein, T, Aguilar, H, Ng, T.I, Liu, Ran, Lin, C.-W, Kort, J, Mensa, F

Volltext

Endurance-3: A Phase 3, Randomized, Open-Label, Active-Controlled Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered with Daclatasvir in Adults w... von Foster, G, Gane, E, Asatryan, A, Pol, S, Poordad, F, Vierling, J, Kort, J, Lin, C.-W, Lovell, S.S, Ng, T.I, Mensa, F

Volltext

MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure von Poordad, F, Pol, S, Asatryan, A, Buti, M, Shaw, D, Hézode, C, Lalezari, J, Felizarta, F, Reindollar, R.W, Gordon, S.C, Pianko, S, Fried, M.W, Bernstein, D.E, Gallant, J, Lin, C.-W, Lei, Y, Ng, T.I, Pilot-Matias, T, Kort, J, Mensa, F

Volltext

Generative adversarial networks for scintillation signal simulation in EXO-200 von Li, S., Ostrovskiy, I., Li, Z., Yang, L., Al Kharusi, S., Anton, G., Barbeau, P.S., Badhrees, I., Beck, D., Belov, V., Bhatta, T., Breidenbach, M., Brunner, T., Cao, G.F., Cen, W.R., Chambers, C., Cleveland, B., Coon, M., Craycraft, A., Daniels, T., Daugherty, S.J., Davis, J., Delaquis, S., Der Mesrobian-Kabakian, A., DeVoe, R., Dilling, J., Dolgolenko, A., Dolinski, M.J., Echevers, J., Fairbank, W., Fairbank, D., Farine, J., Fierlinger, P., Fu, Y.S., Fudenberg, D., Gautam, P., Gornea, R., Gratta, G., Hall, C., Hansen, E.V., Hoessl, J., Hufschmidt, P., Hughes, M., Iverson, A., Jamil, A., Jewell, M.J., Johnson, A., Karelin, A., Kaufman, L.J., Koffas, T., Krücken, R., Kuchenkov, A., Kumar, K.S., Lan, Y., Larson, A., Lenardo, B.G., Leonard, D.S., Li, G.S., Licciardi, C., Lin, Y.H., MacLellan, R., McElroy, T., Michel, T., Mong, B., Moore, D.C., Murray, K., Njoya, O., Nusair, O., Odian, A., Perna, A., Piepke, A., Pocar, A., Retière, F., Robinson, A.L., Rowson, P.C., Schmidt, S., Skarpaas, K., Soma, A.K., Stekhanov, V., Tarka, M., Thibado, S., Todd, J., Tolba, T., Totev, T.I., Tsang, R., Veenstra, B., Veeraraghavan, V., Vogel, P., Vuilleumier, J.-L., Wagenpfeil, M., Weber, M., Wen, L.J., Wichoski, U., Wrede, G., Wu, S.X., Xia, Q., Yahne, D.R., Yen, Y.-R., Zeldovich, O.Ya, Ziegler, T.

Volltext

663 DIFFERENTIAL VIROLOGICAL AND CYTOKINE GENE EXPRESSION PROFILES IN LYMPHOID CELLS OF RESPONDERS AND NONRESPONDERS TO PEGYLATED INTERFERON ALPHA AND RIBAVIRIN COMBINATION THERAPY von Pham, T, Lin, D.M, Michalak, T.I

Volltext